the executive summary really improves the report.

i wonder, if it's really necessary to delete the column with the names of the companies since this is just "raw data" which is available for everyone who does patent-research. i mean, there's no judgment or the like in it, isnt't it? Or is it also possible to get SLAPPed for that?

(few minor corrections)

best
matthias

still have to work on the figures a little bit

I added a shorter executive summary (!ok?)

In the Annex, I deleted the column with the names of the companies - the
most important are named in the text anyway.

_______________________________________________
Npos_2018 mailing list
Npos_2018@testbiotech.de
https://lists.testbiotech.de/cgi-bin/mailman/listinfo/npos_2018

-- 
Dr. Matthias Juhas
Gen-ethisches Netzwerk e.V. (GeN)
Stephanstraße 13
10559 Berlin
Tel. 030-685 7073
Fax: 030-684 1183
eMail: matthias.juhas@gen-ethisches-netzwerk.de
Web: www.gen-ethisches-netzwerk.de
Twitter: @GeNetzwerk